Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Clinical trial NCT07346157 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07346157
Sponsor: Sabine Mueller, MD, PhD
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Medulloblastoma Medulloblastoma, Childhood Medulloblastoma Recurrent

Start date: 2026-07-30
Primary completion: 2031-03-31
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.